An upstate New York maker of antibiotics has scored some government incentives to help cover the cost of expanding its plant in Syracuse.

Teva is reportedly laying off hundreds of workers in the next few months at its struggling sterile injectables plant in Hungary and will sell or close the…

Drugmakers are closing small-molecule plants, but Sanofi is taking the process even further—it will destroy an unused plant it spent about $118 million to…

Thermo Fisher Scientific is acquiring Patheon—the center of the consolidation that has swept through contract manufacturing—in a deal valued at $7.2 billion.

Just eight months after receiving an FDA warning letter for a U.S. plant bought from Sun Pharma, Frontida BioPharm says the plant has been given an all-clear.

Former Allergan Chairman Paul Bisaro will use his tested strategy of M&A and consolidation in his efforts to restore Impax Laboratories' fiscal health…

A U.S. generics manufacturing site that India’s Lupin picked up in its 2015 buyout of GAVIS Pharmaceuticals has now been significantly expanded as the…

The Teva divestment rumors are true. The company wants to sell off its women’s health and European oncology and pain businesses to pay down debt.

Manufacturing